Close
  Indian J Med Microbiol
 

Figure 3: The concentration–time curve of cimifugin in rat plasma after oral administration of cimifugin, prime-O-glucosylcimifugin (PGCN), or 4’-O-β-D-glucosyl-5-O-methylvisamminol (GML). The rats were orally administered with cimifugin (2 or 6 mg/kg), PGCN (6 mg/kg), and GML (6 mg/kg), respectively. Blood samples from rats were then collected 0.5, 1, 1.5, 2,3, 5, 8, and 12 h following the drug delivery for HPLC analysis

Figure 3: The concentration–time curve of cimifugin in rat plasma after oral administration of cimifugin, prime-O-glucosylcimifugin (PGCN), or 4’-O-β-D-glucosyl-5-O-methylvisamminol (GML). The rats were orally administered with cimifugin (2 or 6 mg/kg), PGCN (6 mg/kg), and GML (6 mg/kg), respectively. Blood samples from rats were then collected 0.5, 1, 1.5, 2,3, 5, 8, and 12 h following the drug delivery for HPLC analysis